振东制药(300158.SZ)发布前三季度业绩，归母净利润2036.41万元，下降49.25%

Core Viewpoint - Zhendong Pharmaceutical (300158.SZ) reported a decline in revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's revenue for the first three quarters was 2.215 billion yuan, a year-on-year decrease of 2.42% [1] - The net profit attributable to shareholders was 20.3641 million yuan, down 49.25% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 507,500 yuan, showing a year-on-year increase of 101.67% [1] - Basic earnings per share were 0.0203 yuan [1]